arsenic trioxide has been researched along with dantrolene in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Büsselberg, D; Florea, AM; Splettstoesser, F | 1 |
1 review(s) available for arsenic trioxide and dantrolene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for arsenic trioxide and dantrolene
| Article | Year |
|---|---|
Arsenic trioxide (As2O3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK).
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boron Compounds; Calcium; Calcium Signaling; Cell Line; Cell Line, Tumor; Cell Survival; Dantrolene; DNA Damage; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Inositol 1,4,5-Trisphosphate Receptors; Microscopy, Confocal; Mitosis; Oxides; Ryanodine Receptor Calcium Release Channel; Time Factors | 2007 |